Post-Introduction Evaluation (PIE) of Covid-19 Vaccination in Delhi: Application of WHO Framework
DOI:
https://doi.org/10.56450/JEFI.2025.v3i01.011Keywords:
Adverse Effect Following Immunization, Covid-19, Cold Chain Points, Cold Chain Handlers, Health Facilities, cPIE, Vaccine HesitancyAbstract
The present study was undertaken for the Post-Introduction Evaluation (PIE) of COVID-19 vaccination across different levels of healthcare system in Delhi. It was conducted in accordance with the guideline provided in the WHO PIE tool to assess the COVID-19 vaccine introduction and document strength and weaknesses. The study found that The detailed operational plans were available at state, district and health facility levels. Both electronic and paper-based reporting and recording mechanism were deployed for COVID-19 vaccination. There was neither stock out nor expiry reported for COVID-19 vaccine. There was an AEFI committee functional with availability of a system and written protocol for monitoring and reporting of AEFIs of COVID-19 vaccine
Downloads
References
1. World Health Organization. New Vaccine Post-Introduction Evaluation (PIE) Tool. Geneva: World Health Organization:2010. https://iris.who.int/bitstream/handle/10665/70436/WHO_IVB_10.03_eng.pdf (Accessed on 25-03-2025)
2. World Health Organization. COVID-19 vaccine post-introduction evaluation (cPIE). Geneva, Switzerland: World Health Organization; 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-cPIE-2021.1 (Accessed on 25-03-2025)
3. Ministry of Health and Family Welfare, Government of India. COVID-19 Vaccination India begins World’s Largest Vaccination Drive on 16 January [Internet]. 2021. Available from: https://www.pib.gov.in/PressReleasePage.aspx?PRID=1689112 (Accessed on 25-03-2025)
4. Government of India. Revised Guidelines for implementation of National COVID Vaccination Program. New Delhi: Ministry of Health and Family Welfare, Government of India; 2021. Available from: https://covid19.india.gov.in/document/revised-guidelines-for-implementation-of-national-covid-vaccination-program/ (Accessed on 25-03-2025)
5. Government of India. COVID-19 Vaccines, Operational Guidelines December 2020. New Delhi: Ministry of Health and Family Welfare, Government of India. 2020. https://covid19dashboard.mohfw.gov.in/pdf/COVID19VaccineOG111Chapter16.pdf (Accessed on 25-03-2025)
6. Lahariya C, Paruthi R, Bhattacharya M. How a New Health Intervention Affects the Health Systems? Learnings from Pentavalent Vaccine Introduction in India. The Indian Journal of Pediatrics. 2015;83(4):294-299.
7. Ahmed D, VanderEnde K, Harvey P, et al. Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India-2018-2019. Vaccine. 2022;40 Suppl 1(Suppl 1):A17-A25.
8. Chowdhury AK, Roy T, Faroque AB, Bachar SC, Asaduzzaman M, Nasrin N. et al. A comprehensive situation assessment of injection practices in primary health care hospitals in Bangladesh. BMC Public Health. 2011 Oct 10;11:779.
9. Joshi J, Das MK, Polpakara D, Aneja S, Agarwal M, Arora NK. Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India. Indian J Pediatr. 2018;85(2):139-148.
10. Mittal S, Rawat C, Gupta A, Solanki HK, Singh RK. Adverse Events Following Immunization Among Children Under Two Years of Age: A Prospective Observational Study From North India. Cureus. 2023;15(4):e38356.
11. National Institute of Epidemiology, Indian Council of Medical Research. Report of Programme Implementation Review following Rotavirus vaccine introduction in India - A Rapid assessment. Chennai, India: National Institute of Epidemiology, Indian Council of Medical Research; 2016. Available from: http://www.icmr.nic.in . (Accessed on 25-03-2025)
12. World Health Organization. Report of the post introduction evaluation of Haemophilus influenza type b (Hib) as pentavalent (DPT + HepB + _Hib) vaccine in Tamil Nadu and Kerala, India, 2012. New Delhi: World Health Organization Country Office for India; 2012.
13. Malik A, Haldar P, Ray A, Shet A, Kapuria B, Bhadana S. et al. Introducing rotavirus vaccine in the Universal Immunization Programme in India: From evidence to policy to implementation. Vaccine. 2019 Sep 16;37(39):5817-5824.
14. World Health Organization. Post-Introduction Evaluation (PIE) of Pentavalent (DTP-Hib-Hepatitis B) and Inactivated Polio Vaccines. New Delhi: World Health Organization, Regional office for South East Asia; 2017 https://iris.who.int/bitstream/handle/10665/272402/sea-immun-111.pdf?sequence=1&isAllowed=y (Accessed on 25-03-2025)
15. Lahariya C, Subramanya B P, Sosler S. An assessment of hepatitis B vaccine introduction in India: Lessons for roll out and scale up of new vaccines in immunization programs. Indian Journal of Public Health 2013;57(1):8-14
16. World Health Organization. Post-Introduction Evaluation of Pentavalent Vaccine and Measles-containing Vaccine Second dose in Goa, Gujarat, Haryana, Jammu and Kashmir, Karnataka and Puducherry. New Delhi: World Health Organization, Country Office for India; 2014.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ngangom Kanchan, Vijay Kumar Tiwari, Sherin Raj TP (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
This means that you are free to:
- Share, copy, and redistribute the article in any medium or format
- Adapt, remix, transform, and build upon the article
as long as you provide appropriate credit to the original work, include the authors' names, article title, journal name, and indicate that the work is licensed under CC Attribution-NonCommercial-NoDerivatives 4.0. Any use of the material should not imply endorsement by the authors or the journal.
